RoosterBio's founders have years of relevant technical, operational and regulatory experience and are considered leaders in the fields of Biomanufacturing and Regenerative Medicine. We have a combined 16 years of experience at the major cell and media supply companies including BD, Life Technologies and Lonza, but more importantly, we have spent almost 20 years as cell and tissue technologists, and have an intimate understanding of the cell supply needs of researchers. The team at RoosterBio leads the field of new-thinkers in stem cell research and commercialization. We are committed to simplifying, de-risking, and de-bottlenecking your lab, liberating you to do more high-impact research. RoosterBio, Inc. aims to radically change the way that scientists use stem cells and to propel the industrialization of regenerative technologies.Headquarters United Stateswork
RoosterBio, Inc. aims to radically change the way that scientists use stem cells and to propel the industrialization of regenerative technologies. RoosterBio is enabling living cellular technologies to become more affordable, easier to access, and much simpler to incorporate into product development efforts, leading to a rapid acceleration in products coming to market that incorporate these technologies. Advancements in bioprinting are driving regenerative medicine, and we are providing the cellular bioink in this rapidly developing market. We believe that we can help shape this new market by making stem cells abundant, affordable, and much simpler to translate into the clinic.